Increased Fucosylation of Glycolipids in a Human Leukaemia Cell Line (K562-Clone I) with Decreased Sensitivity to NK-mediated Lysis
Overview
Affiliations
A subpopulation of human lymphoid cells called natural killers is able to lyse certain normal and neoplastic targets in an in vitro cytotoxicity assay. The molecules which enable them to recognize sensitive cells, or permit tumour cells to escape remain unknown. In the studies described here we have compared some of the plasma membrane characteristics of a NK-sensitive human leukaemia cell line (K562) with those of a partially resistant subclone derived from it (K562-Clone I). Gel electrophoresis of cell-surface proteins radiolabelled by lactoperoxidase-catalysed iodination, periodate-borohydride tritiation, or biosynthetically by incubation with [3H]fucose did not reveal any reproducible differences between the sensitive and resistant lines. However, analysis of glycolipids showed that Clone I incorporated significantly more fucose than did the parental line, and that it synthesized a minor population of complex structures not found in the original K562. A subclone of Clone I (Clone I-Con Ar1), made resistant to the toxic effects of concanavalin A, became sensitive once again to NK, and showed the parental glycolipid profile. These results suggest that the Clone I line, selected for resistance to NK, may have altered one or more of its intermediate oligosaccharides or pathways of fucose incorporation into glycolipid, and points to one process by which a tumor cell might modulate its surface to escape recognition by natural killers.
The Anticancer Activity of Monosaccharides: Perspectives and Outlooks.
McCallum N, Najlah M Cancers (Basel). 2024; 16(16).
PMID: 39199548 PMC: 11353049. DOI: 10.3390/cancers16162775.
Vaddamanu S, Saini R, Veerabasavaiah B, Hussain Alhamoudi F, Alshadidi A, Giudice A Heliyon. 2024; 10(2):e24211.
PMID: 38312635 PMC: 10835230. DOI: 10.1016/j.heliyon.2024.e24211.
Assessment of Serum Fucose Level among Oral Squamous Cell Carcinoma Patients: A Case-Control Study.
Ashem A, Mehta D, Singh D, Singh K, Anupriya C, Devi A J Pharm Bioallied Sci. 2023; 15(Suppl 2):S878-S880.
PMID: 37694091 PMC: 10485465. DOI: 10.4103/jpbs.jpbs_91_23.
Arthisri A, Sathiyamoorthy A, Meenakshi B, Chandran C Contemp Clin Dent. 2020; 11(2):131-135.
PMID: 33110325 PMC: 7583536. DOI: 10.4103/ccd.ccd_336_20.
Beregova T, Neporada K, Skrypnyk M, Falalyeyeva T, Zholobak N, Shcherbakov O EPMA J. 2017; 8(1):43-49.
PMID: 28620442 PMC: 5471807. DOI: 10.1007/s13167-017-0085-7.